RSV fusion (F) protein DNA vaccine provides partial protection against viral infection

Virus Research

Volumn 145, Issue 1, 2009, Pages 39-47

  Wu, Hongzhuan ^a   Dennis, Vida A ^a   Pillai, Shreekumar R ^a   Singh, Shree R ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Cholera toxin; DNA vaccine; Fusion protein; Mucosal vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS INFECTION; SPLEEN CELL; TH1 CELL; TH2 CELL; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CERCOPITHECUS AETHIOPS; CHOLERA TOXIN; COS CELLS; DNA, VIRAL; FEMALE; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINES, DNA; VIRAL FUSION PROTEINS;

MUS; RICE STRIPE VIRUS;

EID: 69449097073     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.06.012     Document Type: Article

References (43)

1. Anderson L., Hierholzer J.C., Bingham P.G., and Stone Y.O. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J. Clin. Microbiol. 22 (1985) 1050-1052
2. Arrington J., Braun R.P., Dong L., Fuller D.H., Macklin M.D., Umlauf S.W., Wagner S.J., Wu M.S., Payne L.G., and Haynes J.R. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvant for DNA vaccines. J. Virol. 76 9 (2002) 4536-4546
3. Bahloul C., Jacob Y., Tordo N., and Perin P. DNA based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16 (1998) 417-425
4. Barouch D.H., Letvin N.L., and Seder R.A. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev. 202 (2004) 266-274
5. Bembridge G.P., Rodriguez N., Garcia-Beato R., Nicolson C., Melero J.A., and Taylor G. DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J. Gen. Virol. 81 (2000) 2519-2523
6. Bleek G.M., Poelen M.C., Most R.V., Brugghe H.F., Timmermans H.A., Boog C.J., Hoogerhout P., Otten H.G., and Els C.A. Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J. Virol. 77 2 (2003) 980-988
7. Bray P. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Virology 263 (1989) 166-174
8. Connors M., Collins P.L., Firestone C.-Y., and Murphy B.R. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65 (1991) 1634-1637
9. Dudas R.A., and Karron R.A. Respiratory syncytial virus vaccine. Clin. Micro. Rev. 11 3 (1998) 430-439
10. Ganapamo F., Dennis V.A., and Philipp M.T. Differential acquired immune responsiveness to bacterial lipoproteins in Lyme disease-resistant and -susceptible mouse strains. Eur. J. Immunol. 33 (2003) 1934-1940
11. Girard M.P., Cherian T., Pervikov Y., and Kieny M.P. A review of vaccine research and development: human acute respiratory infections. Vaccine 23 (2005) 5708-5724
12. Godefroy S., Goestch L., Plotnicky-Gilquin H., Ngueyen T., Schmitt D., Staquet M.-J., and Corvaia N. Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against Respiratory Syncytial Virus (RSV). Vaccine 21 (2003) 1665-1671
13. Graham B.S., Bunton L.A., Wright P.F., and Karzon D.T. Reinfection of mice with respiratory syncytial virus. J. Med. Virol. 34 (1991) 7-13
14. Hajishengallis G., Hollingshead S.K., Koga T., and Russell M.W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154 (1995) 4322-4332
15. Harcourt J.L., Anderson L.J., Sullender W., and Tripp R.A. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles. Vaccine 22 17-18 (2004) 2248-2260
16. Hardy S.J.S., Holmgren J., Johansson S., and Sanchez J. Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro. Proc. Natl. Acad. Sci. USA 85 (1988) 7109-7113
17. Hurk S.V., Mapletoft J.W., Arsic N., and Kovacs-Nolan J. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev. Med. Virol. 17 1 (2007) 5-34
18. Iqbal A., Lin W., Jabbal-Gill I., Davis S.S., Steward M.W., and Illum L. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 21 (2003) 1478-1485
19. Justewicz D., and Webster R.G. Long term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology 224 (1996) 10-17
20. Klinman D.M. Adjuvant activity of CpG oligodeoxynucleotides. Int. Rev. Immunol. 25 (2006) 135-154
21. Le T.T., Drane D., Malliaros J., Cox J.C., Rothel L., Pearse M., Woodberry T., Gardner J., and Suhrbier A. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. Vaccine 19 (2001) 4669-4675
22. Li X., Sambhara S., Li C.X., Ewasyshyn M., Parrington M., Caterini J., James O., Cates G., Du R.-P., and Klein M. Protection against respiratory syncytial virus infection by DNA immunization. J. Exp. Med. 188 (1998) 681-688
23. Lycke N. The mechanism of cholera toxin adjuvanticity. Res. Immunol. 148 (1997) 504-520
24. Martinez-Sobrido L., Gitiban N., Fernandez-Sesma A., Cros J., Mertz S.E., Jewell N.A., Hammond S.A., Flano E., Durbin R.K., Garcia-Sastre A., and Durbin J.E. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J. Virol. 80 3 (2006) 1130-1139
25. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P.H., and Siegrist C.-A. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte response in neonates and during early life. Proc. Natl. Acad. Sci. USA 94 (1997) 8726-8731
26. Munoz F.M., Piedra P.A., and Glenzen W.P. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 24 (2003) 3465-3467
27. Ogra P.L., Faden H., and Welliver R.C. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14 (2001) 430-445
28. Perrie Y., Frederik P.M., and Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19 (2001) 3301-3310
29. Pertmer T.M., Roberts T.R., and Haynes J.R. Influenza virus nucleoprotein specific immunoglobulinG subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70 (1996) 6119-6125
30. Sanchez A.E., Aquino G., Ostoa-Saloma P., Laclette J.P., and Rocha-Zavaleta L. Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccine. Clin. Diagn. Lab. Immunol. 11 (2004) 711-719
31. Simmons C., Hussell T., Sparer T., Walzl G., Openshaw P., and Dougan G. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic and immunoregulatory antiviral CD8+ T cell responses. J. Immunol. 166 2 (2001) 1106-1113
32. Singh S.R., Dennis V.A., Carter C.L., Pillai S.R., Jefferson A., Sahi S.V., and Moore E.G. Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model. Vaccine 25 (2007) 6211-6223
33. Singh S.R., Dennis V.A., Carter C.L., Pillai S.R., and Moore E.G. Respiratory Syncytial Virus Recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice. Viral Immunol. 20 2 (2007) 261-275
34. Singh S.R., Hulett K., Pillai S.R., Dennis V.A., Oh M.K., and Scissum-Gunn K. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Vaccine 24 (2006) 1213-1224
35. Sixma T.K., Pronk S.E., Kalk K.H., Van B.A., Berghuis A.M., and Hol W.G. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography. Nature 355 6360 (1992) 561-564
36. Tebbey P.W., Scheuer C.A., Peek J.A., Zhu D., LaPierre N.A., Green B.A., Phillips E.D., Ibraghimov A.R., Eldridge J.H., and Hancock G.E. Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H. Vaccine 18 (2000) 2723-2734
37. Tree J.A., Bembridge G.P., Hou S., Taylor G., Fashola-Stone E., Melero J., and Carnage M.P. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung. Vaccine 22 (2004) 2438-2443
38. Tripp R.A., Oshansky C., and Alvarez R. Cytokines and respiratory syncytial virus infection. Proc. Am. Thorac. Soc. 2 (2005) 147-149
39. Ulmer J.B., Sadoff J.C., and Liu M.A. DNA vaccines. Curr. Opin. Immunol. 8 (1996) 531-536
40. Vaughan K., Rhodes G.H., and Gershwin L.J. DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. Vaccine 23 (2005) 2928-2942
41. Walsh E.E. Humoral, mucosal and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine. J. Infect. Dis. 170 (1994) 345-350
42. Walsh E.E., and Falsey A.R. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J. Infect. Dis. 190 (2004) 373-378
43. Wertz G.W., Stott E.J., Young K.K.Y., Anderson K., and Ball L.A. Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J. Virol. 61 (1987) 293-301